Figure 1. Inducible Expression of BRCA1 (A) Northern blot analysis of total cellular RNA from cells with inducible expression of BRCA1 (24 hr after tetracycline withdrawal): U2OS-derived UBR60 (wild-type BRCA1) and UBR60-mt cells (mutant BRCA1), and MDA435-derived MBR62 cells (wild-type BRCA1). The endogenous
We used immunofluorescence analysis, with antibody ern and Western blot analyses in both cell lines showed tightly regulated induction of BRCA1 expression (Fig-MS13 directed against the N terminus of BRCA1, to compare expression of inducible BRCA1 with that of the ures 1A and 1B). Low levels of endogenous 7.8 kb BRCA1 mRNA were detectable when cells were grown endogenous protein within individual cells ( Figure 1C ). Nuclear expression of inducible BRCA1 was evident, in the presence of tetracycline, and drug withdrawal led to induction of the expected 5.6 kb transfected BRCA1 although some cytoplasmic staining was also observed in rare cells expressing high levels of BRCA1. Similar transcript. A number of smaller mRNA species were also observed, presumably resulting from the activation of results were obtained with antibody 12-CA-5 (data not shown). Cellular heterogeneity, a common feature of cryptic splice sites within the transfected cDNA (Wilson et al., 1997) , but these comprised only a small fraction tetracyline-inducible cell lines, was evident following withdrawal of tetracycline, with the range of inducible of the polyadenylated transcript (data not shown). Analysis of inducible protein expression, using immunopreexpression estimated as 2-to 10-fold that of the endogenous protein (see below). This relatively modest protein cipitation with antibody C20 directed against the C terminus of BRCA1, followed by immunoblotting using induction, compared with the more dramatic induction of BRCA1 mRNA ( Figure 1A ), is consistent with reduced antibody 12-CA-5 against the N-terminal epitope tag, identified only the expected 220 kDa full-length BRCA1 translational efficiency of the transfected transcript. It was noted that UBR60 cells lost inducible BRCA1 ( Figure 1B ). U2OS cells were also generated with inducible expression of a mutant BRCA1 allele, containing a expression following continued growth in tetracycline, Figure 1D ), suggesting that hypermethylation of the tetracycline-BRCA1, we stably transfected UBR60 cells with human papillomavirus (HPV16) E6, which targets p53 for degraresponsive BRCA1 promoter was responsible for its suppression and presumably for the heterogeneity of dation (the resulting cells were called UBR60-E6). Western blotting confirmed the expression of E6 and the BRCA1 expression in these cells. reduction in both baseline and IR-induced levels of p21 that indicate abrogation of p53 function ( Figure 2D ).
Induction of Apoptosis by BRCA1
To determine the effect of BRCA1 induction in UBR60 Induction of BRCA1 in UBR60-E6 cells inhibited colony formation to the same extent as in parental UBR60 cells, cells, we first measured their ability to form colonies in the presence or absence of tetracycline. An 80% reducindicating that this effect was independent of p53 (Figure 2A) . tion in colony formation was observed following induction of BRCA1 (Figure 2A ). In contrast, withdrawal of In examining cells at early time points following withdrawal of tetracycline, we observed that expression of tetracycline had only a very modest effect on colony formation in UBR60-mt cells, expressing the mutant the induced BRCA1 transcript was unexpectedly transient. The induced BRCA1 mRNA was first detectable BRCA1 transcript. The inhibition of colony formation by BRCA1 was also evident in the MBR62 breast cancer in both UBR60 and MBR62 cells at 6 hr, peaked at 24 hr, and declined to virtually undetectable levels by cells. Of note, these cells have mutant endogenous p53 (G to E at codon 226), in contrast to U2OS cells, in which 96 hr ( Figure 2B ). In contrast, UBR60-mt cells showed Saito, 1998). Induction of GADD45 mRNA was virtually coincident with BRCA1 expression, detectable within 3 1 (EGR1) (10-fold). Oligonucleotide array hybridization also identified a small number of potential targets that hr of tetracycline withdrawal ( Figure 5A ). The level of GADD45 induction by BRCA1 in U2OS cells was compawere repressed following BRCA1 expression, but these could not be confirmed by Northern blotting, since their rable to that induced by known stimuli, overexpression of wild-type p53, or IR (20Gy), and higher than that inbaseline expression levels were below detection. However, two expression changes of possible interest were duced by UV (20J/m 2 ) in these cells ( Figure 5B ). In UBR60 cells, lacking bcl2, induction of GADD45 was also eviin the genes Ki-67 (12-fold repression) and prothymosin ␣ (4-fold repression; data not shown). These genes have dent, mirroring the transient expression of BRCA1 in these cells (data not shown). At least two distinct pathbeen previously implicated as possible prognostic markers in breast cancer, and Ki-67 expression in this tumor ways leading to the induction of GADD45 have been identified. IR triggers the ATM-and p53-dependent ina second BRCA1-responsive site within intron 1, which was also p53 dependent, while the GADD45 proximal duction of GADD45, mediated through a p53-responsive element within intron 3 (Kastan et al., 1992) . Other stimpromoter was not activated by expression of BRCA1 ( Figure 5C ). To determine whether presence of p53 uli, including UV irradiation and treatment with alkylating agents (so-called "MUM" stress, for methyl methanesulwas indeed required for BRCA1-mediated induction of endogenous GADD45, UBR60-bcl2 cells were stably fonate [MMS], UV irradiation, and medium starvation) lead to the induction of GADD45 by a p53-independent transfected with HPV16 E6 (resulting cells were called UBR60-bcl2-E6). However, inactivation of endogenous pathway, which may involve elements within the proximal GADD45 promoter (Hollander et al., 1993) . p53 in these cells did not alter the potent BRCA1-mediated induction of endogenous GADD45 ( Figure 5D ). SimGiven previous reports that BRCA1 modulates p53-mediated transcriptional activation ( To test the p53-independent pathway leading to the induction of GADD45, we used MMS, an alkylating agent known to induce GADD45 in all cells tested (Kastan et al., 1992) . As expected, treatment of both the p53 wildtype cells MCF7 and the p53 mutant cells MDA435 with 100 g/ml of MMS resulted in potent induction of GADD45 ( Figure 5E ). Remarkably, minimal induction of GADD45 was observed in HCC1937, a recently discovered breast cancer cell line, harboring a mutation in both BRCA1 and p53 (Tomlinson et al., 1998) . Baseline expression of GADD45 was elevated in HCC1937 cells but considerably lower than induced levels in other cell lines, indicating that induction by MMS would have been readily detectable. Thus, in this BRCA1 mutant cell line, the p53-independent regulation of GADD45 appears to be compromised. The primary phenotype observed following forced expression of wild-type BRCA1 is programmed cell death. transfected the dominant-negative SEK1 mutant into U2OS cells expressing the temperature-sensitive p53
Analysis of Other Potential
This effect is so prompt that BRCA1 expression is detectable for only 24 hr following withdrawal of tetracyallele. Inhibition of JNK/SAPK function in these cells had no effect on p53-mediated apoptosis (data not shown).
cline, whereupon cells expressing BRCA1 are lost from the culture and replaced with cells whose inducible proin the p53-independent activation of GADD45 will need to be confirmed once genetically defined BRCA1-null moter has been silenced through hypermethylation. The characterization of this cell death process as apoptotic cells are available. We did not observe activation of the proximal GADD45 promoter following overexpression of is based on its abrogation by peptides that specifically inhibit the caspases required for apoptosis, as well as BRCA1 itself, in either transient transfection assays or following stable chromosomal integration of reporter its delay by constitutive expression of the antiapoptotic gene bcl2. PARP cleavage and TUNEL staining, characconstructs (data not shown). The BRCA1-responsive site may therefore be located at some distance from teristics of cells undergoing apoptosis, are evident as the protective effect of ectopically expressed bcl2 is known GADD45 regulatory sequences. Our observations have implications for the paradoxioverwhelmed. BRCA1-induced cell death appears to be mediated primarily through the JNK/SAPK stress recal interactions between BRCA1 and p53. While BRCA1 activates the p21 promoter, either alone or in cooperasponse pathway. Signaling through JNK/SAPK is known to be triggered by UV irradiation, osmotic stress, and in tion with p53 ( A potential mechanism for the activation of JNK/SAPK 3 of GADD45, but BRCA1-mediated induction of endogenous GADD45 is largely independent of p53. We also by BRCA1 is provided by its induction of GADD45, a gene whose product has recently been reported to bind have observed neither activation nor repression of endogenous p21, following inducible expression of BRCA1. and activate an upstream regulator of JNK/SAPK, the MAPKKK MTK1/MEK4, triggering JNK/SAPK-depenThe cooperative effect of BRCA1 and p53 in promoterreporter assays therefore may not predict a physiologident apoptosis (Takekawa and Saito, 1998). It is unclear whether GADD45 is required for the activation of JNK/ cal effect on endogenous target genes, at least in the cell lines that we examined. The increased expression SAPK in response to DNA damage, and analysis of GADD45-null cells will be required to determine whether of p21 in BRCA1-null embryos is unlikely to result from loss of BRCA1-mediated transcriptional repression, but it is necessary for BRCA1-mediated apoptosis. GADD45 itself may have additional functional properties. In this rather from the activation of p53 in response to the accumulation of DNA damage. context, it is of interest to note that preventing BRCA1-mediated apoptosis by constitutive expression of the dominant-negative SEK1 mutant uncovered a cellular Expression Profiling to Define Functional Pathways proliferation defect in cells overexpressing BRCA1 (FigFinally, hybridized to a set of four arrays, which together enabled interrogapromoter hypermethylation, UBR60 cells that had lost inducible extion of the expression levels of 6800 human genes and ESTs. Minimal pression following prolonged growth in tetracycline were treated variation was observed following independent hybridization of idenwith 2 g/ml 5-azaC (Sigma) for 24 hr on days 1 and 4, followed by tical RNA samples, and no significant expression differences were withdrawal of tetracycline on day 7, RNA isolation on day 8, and found to be induced in U2OS cells by the presence or absence of Northern blot analysis. Cell lines with constitutive expression of tetracycline itself. Following quantitative expression analysis (Lock-CMV-driven bcl2 or HPV16 E6 were generated by stable transfection hart et al., 1996; Wodicka et al., 1997), a list of candidate BRCA1 of UBR60 cells along with a hygromycin resistance plasmid. Cells targets was assembled by identifying genes that were progressively with constitutive expression of the CMV-driven dominant-negative induced or repressed in at least two different time points and dis-SEK1 mutant (kindly provided by L. Zon, Harvard Medical School) played an expression change of at least 2-fold. All targets were were generated by cotransfection with XGPT and selection in HAT.
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